2022-12-15
Editor-in-Chief: Dr. Zhiping Xu
Frequency: Half-yearly
Time to first decision: 2.4 Weeks
Submission to publication: 4 Weeks
ISSN: 2972-3388
Open Access Statement | Privacy Statement | Copyright Policy | Publishing Ethics | Archiving Policy | Crossmark Policy | Revenue Sources | Contact Information
Contact Email: CancerInsight@anser.press | ISSN: 2972-3388 | © 2020-2023 Anser Press Pte.Ltd. All rights reserved
Indexed by
Published by